Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUltrasis Plc Regulatory News (ULT)

  • There is currently no data for ULT

Statement re new distribution

4 Jun 2008 07:00

RNS Number : 7858V
Ultrasis PLC
04 June 2008
 



Ultrasis plc

Beating the Blues now available for private patients

Ultrasis meets growing private demand for access to anxiety and depression therapy

Ultrasis plc, the provider of interactive healthcare and associated services, is pleased to announce the launch of Beating the Blues Connect. Beating the Blues Connect will combine on-line therapy with 24/7 telephonic support, to meet the growing demand from private patients for confidential and immediate access to treatment for mild and moderate depression and anxiety related problems.  The initial price of Beating the Blues Connect, which includes 16 weeks telephonic support and one year's access to Beating the Blues will be £325.00.

An estimated six million people suffer from anxiety and depression in the UK and evidence indicates that in excess of 25% of people with mental health problems do not go to their GP or the NHS for supportoften to preserve confidentialityIn response, Ultrasis is making its flagship Beating the Blues programme available for private use.

Beating the Blues Connect will be delivered by LTL Connect which will provide the service through its dedicated 24 hour call centre in Cardiff. LTL Connect is renowned for delivering wellbeing services on behalf of the Teacher Support Network to over 800,000 Teachers and Educational Staff in the UK and for its involvement in the Welsh 'Healthy Minds at Work' programme.

 

Nigel Brabbins, Ultrasis' Chief Executivesaid: 

"Since the National Institute for Health and Clinical Excellence recommended Beating the Blues for use across the NHS there has been a rising tide of demand from private patients. It's widely known that many people don't want to go to traditional services to receive support, many choosing to pay reasonable price for convenience, ease of access and confidentiality. Beating the Blues Connect will meet this demand, providing a high quality, evidence based way of helping people to recover their emotional well-being. The price for this cutting edge product is highly competitive.

He added: "The partnership we have developed with LTL Connect to deliver this retail version will also enable us to look at opportunities to deliver bespoke packages into the workplace, enabling employers to address mental health issues as part of their duty of care

"The launch of Beating the Blues Connect, as heralded in the recent interim statement, creates another opportunity to extend sales activity beyond the NHS, where Ultrasis continues to experience high renewal rates, sustained income growth and increased market penetration."

Patrick Nash, LTL Connect Chief Executive said:

"With more and more people experiencing depression and limited availability of therapy, Beating the Blues Connect is an effective, supported way people can get help and feel better. It not only represents good value, but there are no waiting lists, it removes any stigma and puts people in control of their own treatment plan. LTL Connect has significant experience in supporting and counselling people with a range of common mental heath problems and will provide reliable support to people using Beating the Blues Connect."

To find out more about Beating the Blues Connect, visit, www.thewellnessshop.co.uk

- ends -

For further information please contact:

Ultrasis plc:

Nigel Brabbins, Chief Executive

+44 (0) 20 7566 3900

nbrabbins@ultrasis.com

www.ultrasis.com

FinnCap, NOMAD and Joint Broker

Geoff Nash

+44 (0) 20 7600 1658

Notes to editors:

About Ultrasis plc

Cognitive Behavioural therapy (CBT) is the psychological treatment of choice for people suffering from anxiety and depression. NICE clinical guidelines for  anxiety and depression (published in Dec 2004) emphasised the importance of this therapy and at the same time recommended that sufferers from mild depression should not, initially, be given drugs but self-help material, preferably based on CBT, should be offered. 

In February 2006 The National Institute for Health & Clinical Excellence (NICE) recommended using Beating the Blues for delivering Cognitive Behavioural Therapy (CBTby computer in the management of mild and moderate depression. 

Beating the Blues is an eight-week, web-based treatment programme for depression based on Cognitive Behavioural Therapy. Following a rigorous examination by the National Institute for Health and Clinical Excellence (NICE), 

Seven out of Ten patients suffering from depression who used Beating the Blues® required no further treatment. Waiting lists for face to face therapy extend to 18 months in some areas. 

Ultrasis was the first company to offer computerised products based on Cognitive Behavioural Therapy (CBT) and interactive multimedia, and is the world leader in the field. The products help people tackle stress, anxiety and depression, and a full spectrum of related chronic conditions.

www.ultrasis.com 

www.thewellnessshop.co.uk

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STREAKKAEELPEFE
Date   Source Headline
19th Sep 20117:00 amRNSMajor new initiative in the Netherlands
12th Sep 20117:00 amRNSBeating the Blues to be used in US Army Research
10th May 20113:00 pmRNSBlocklisting Interim Review
7th Mar 20117:00 amRNSHalf Yearly Report
10th Feb 201111:31 amRNSHolding(s) in Company
31st Jan 20117:00 amRNSResult of AGM
27th Jan 20117:00 amRNSAnnouncement of new partnership agreement
10th Jan 20117:00 amRNSNew contract
23rd Dec 20109:00 amRNSAnnual Report and Accounts Posting
20th Dec 20107:00 amRNSChange of Adviser
30th Nov 20107:00 amRNSFinal Results
9th Nov 201010:29 amRNSBlock Admission of Shares
3rd Nov 20107:00 amRNSStrategic Partnership
15th Sep 20107:00 amRNSBreakthrough in New Zealand
3rd Sep 20108:55 amRNSHolding(s) in Company
26th Aug 20107:00 amRNSNew contract
30th Jun 201010:34 amRNSChange of Registered Office and name of Adviser
26th Apr 20107:01 amRNSNew contract
26th Apr 20107:00 amRNSHalf Yearly Report
1st Apr 20107:00 amRNSInsomnia Research Project
30th Mar 20107:00 amRNSRe reimbursement for Beating the Blues
16th Mar 20107:00 amRNSNew contract
11th Feb 20107:00 amRNSStrategic collaboration
9th Feb 20107:00 amRNSNew Territory
28th Jan 20105:22 pmRNSResult of AGM
26th Jan 20107:00 amRNSEU research grant in ICT applied to mental health
21st Dec 20092:00 pmRNSPosting of Annual Report and Accounts
4th Nov 20097:01 amRNSDirectorate Change
4th Nov 20097:00 amRNSFinal Results
28th Oct 20092:08 pmRNSCorrection re NICE Guidance
28th Oct 200912:09 pmRNSNICE Guidance
8th Oct 20091:12 pmRNSRoll-out of product in the Netherlands
31st Jul 20097:00 amRNSIssue of Equity
22nd Jul 20098:25 amRNSContract renewed
11th May 200911:06 amRNSHolding(s) in Company
23rd Mar 20091:46 pmRNSHolding(s) in Company
11th Mar 20097:00 amRNSContract Win
3rd Mar 200912:48 pmRNSHolding(s) in Company
27th Feb 20099:19 amRNSResult of AGM
23rd Feb 20091:00 pmRNSInterim Results
20th Feb 200910:03 amRNSContract win
11th Feb 20093:00 pmRNSDoc re. AGM resolutions
27th Jan 20092:51 pmRNSTotal Voting Rights
27th Jan 20092:45 pmRNSAnnual Report and Accounts
18th Dec 20081:24 pmRNSAcquisition
4th Dec 20082:51 pmRNSResult of EGM
3rd Dec 20087:00 amRNSSpeech by Alan Johnson
26th Nov 20087:00 amRNSContract Win
25th Nov 20087:00 amRNSExtension of contract
17th Nov 20088:37 amRNSCorrection re new contract

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.